Longevity Biotech Australia Pty Ltd (subsidiary)

This early-stage trial evaluates the safety and tolerability of an investigational drug called LBT-3627, a synthetic peptide, in healthy adults and in people with Parkinson's disease. Participants receive either the drug or a placebo, and researchers monitor side effects and how …